IntoCell, Inc. (KOSDAQ:287840)
South Korea
· Delayed Price · Currency is KRW 66,200
-4,800 (-6.76%)
At close: Dec 5, 2025
IntoCell Revenue
IntoCell had revenue of 1.42B KRW in the quarter ending September 30, 2025, with 44.41% growth. This brings the company's revenue in the last twelve months to 1.68B, down -39.84% year-over-year. In the year 2024, IntoCell had annual revenue of 2.91B with 79.72% growth.
Revenue (ttm)
1.68B
Revenue Growth
-39.84%
P/S Ratio
583.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
982.91B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |